Search Results 3831-3840 of 33501 for oral

  1. Throat cancer - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oropharynx Cancer Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic ...

  2. Shawna L. Ehlers, Ph.D., L.P. - Doctors and Medical Staff - Mayo Clinic

    Best of the Best Oral Presentation (role: co-mentor)American Psychosocial Oncology Society ... Best Abstract for oral presentationBlood and Marrow ...

  3. A Study to Evaluate Intravenous Iloprost in Subjects with Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis - Mayo Clinic

    Subjects who have initiated or had a dose change of any of the following within 2 weeks of screening: oral, topical, or IV vasodilators (e.g., calcium ...

  4. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

    * Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable ...

  5. Neuroendocrine tumors - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Microvascular surgery, Facial reconstruction, Skull base surgery, Glossectomy, Tracheostomy, Skin cancer reconstruction, Submandibular gland ...

  6. Gastrointestinal Disorders Clinical Trials - Mayo Clinic Research

    GII is a condition that is defined as the failure of oral re-feeding after abdominal surgery. A Study of the Effect of the Vibrant Capsule on Gastric ...

  7. TMJ disorders - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Physical Medicine and Rehabilitation. Doctors who treat this condition. Edit search filters. close. Narrow your search. By ...

  8. A Study to Evaluate the Safety, Effectiveness, and Tolerability of Latiglutenase to Treat Patients with Well-Controlled Celiac Disease - Mayo Clinic

    Taking any oral probiotic supplements (not including probiotics contained in commercially available food preparations) 6 months prior to entry. Use of any ...

  9. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial (FASTEST) - Mayo Clinic

    Secondary ICH related to known causes (e.g., trauma, aneurysm, arteriovenous malformation (AVM), oral anticoagulant use (vitamin K antagonists or novel oral ...

  10. Surgery - Doctors - Mayo Clinic

    James M. Van Ess, M.D., D.D.S.. Oral and Maxillofacial Surgeon. Rochester, MN ...